SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 121 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,501,000 | +192.5% | 1,236,493 | +275.2% | 0.00% | – |
| Q3 2016 | $1,539,000 | -41.2% | 329,515 | -17.2% | 0.00% | -100.0% |
| Q2 2016 | $2,616,000 | +147.3% | 398,175 | +139.4% | 0.00% | – |
| Q1 2016 | $1,058,000 | -44.3% | 166,322 | -47.2% | 0.00% | – |
| Q4 2015 | $1,899,000 | -36.6% | 314,856 | -37.1% | 0.00% | -100.0% |
| Q3 2015 | $2,996,000 | -82.0% | 500,927 | -79.4% | 0.00% | -75.0% |
| Q2 2015 | $16,651,000 | +17.7% | 2,434,507 | +4.5% | 0.00% | 0.0% |
| Q1 2015 | $14,146,000 | +125.8% | 2,330,557 | +157.7% | 0.00% | +100.0% |
| Q4 2014 | $6,266,000 | -15.8% | 904,217 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $7,444,000 | +1.4% | 914,464 | +1.3% | 0.00% | 0.0% |
| Q2 2014 | $7,340,000 | +8.3% | 902,839 | +4.4% | 0.00% | 0.0% |
| Q1 2014 | $6,777,000 | -14.5% | 864,409 | -3.5% | 0.00% | 0.0% |
| Q4 2013 | $7,925,000 | -1.7% | 895,467 | -6.8% | 0.00% | -33.3% |
| Q3 2013 | $8,064,000 | +7.7% | 961,067 | -4.2% | 0.00% | +50.0% |
| Q2 2013 | $7,486,000 | – | 1,003,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |